Citation tools
"A Phase II, Open-label study to assess safety and management change using 68Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.." Journal of Nuclear Medicine
(2021):
jnumed.120.257527.
Web. 18 April. 2024.